These data validate the concerns raised by the cIMPACT-NOW updates and the WHO 2021 classification regarding the heterogeneity of histologically diagnosed low-grade IDH-wt astrocytomas. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).